Similar Articles

  • ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease

    Cara Reiter-Brennan, Albert D. Osei, MD, MPH, S. M. Iftekhar Uddin, MBBS, MSPH, Olusola A. Orimoloye, MD, MPH, Olufunmilayo H. Obisesan, MD, MPH, Mohammadhassan Mirbolouk, MD, Michael J. Blaha, MD, MPH and Omar Dzaye, MD, PhD
    • Cleveland Clinic Journal of Medicine April 2020, 87 (4) 231-239;
    • DOI: https://doi.org/10.3949/ccjm.87a.19078

    • Risk assessment, drugs, patient subgroups, value of therapy, personalized plans, and shared decision-making.

  • 2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What’s new?

    Steven L. Cohn, MD
    • Cleveland Clinic Journal of Medicine April 2025, 92 (4) 213-219;
    • DOI: https://doi.org/10.3949/ccjm.92a.24125

    • The author highlights key changes and recommendations of the new guideline, how they differ from previous and other society guidelines, and ongoing challenges and unresolved issues in perioperative care.

  • 2017 ACC/AHA hypertension guidelines: Toward tighter control

    Rebecca Blonsky, MD, Marc Pohl, MD, Joseph V. Nally Jr, MD and George Thomas, MD
    • Cleveland Clinic Journal of Medicine October 2018, 85 (10) 771-778;
    • DOI: https://doi.org/10.3949/ccjm.85a.18028

    • Under the new defi nition (≥ 130/80 mm Hg), 46% of US adults have hypertension.

  • Residents’ Knowledge of ACC/AHA Guidelines for Preoperative Cardiac Evaluation Is Limited

    BobbieJean Sweitzer, MD, Michael Vigoda, MD, MBA, Nikola Milokjic, Ben Boedeker, DVM, MD, PhD, MBA, Kip D. Robinson, MD, FACP, Michael A. Pilla, MD, Robert Gaiser, MD, Angela F. Edwards, MD, Ronald P. Olson, MD, Matthew D. Caldwell, MD, Shawn T. Beaman, MD, Jeffrey A. Green, MD, Jesse M. Ehrenfeld, MD, MPH, Marsha L. Wakefi eld, MD, Praveen Kalra, MD, David M. Feinstein, MD, Deborah C. Richman, MBChB, FFA(SA), Gail Van Norman, Gary E. Loyd, MD, MMM, Paul W. Kranner, MD, Stevin Dubin, MD, Sunil Eappen, MD, Sergio D. Bergese, MD, Suzanne Karan, MD, James R. Rowbottom, MD, FCCP and Keith Candiotti, MD
    • Cleveland Clinic Journal of Medicine March 2010, 77 (3 esuppl 1) eS11-eS12;

  • Contemporary management of peripheral arterial disease

    Amjad AlMahameed, MD, John R. Bartholomew, MD, Heather L. Gornik, MD, MHS and Mark A. Creager, MD
    • Cleveland Clinic Journal of Medicine October 2006, 73 (10 suppl 4) S30-S37;

  • Contemporary management of peripheral arterial disease

    Amjad AlMahameed, MD, MPH, FACP, John R. Bartholomew, MD and Deepak L. Bhatt, MD, FACC, FSCAI, FESC, FACP
    • Cleveland Clinic Journal of Medicine October 2006, 73 (10 suppl 4) S45-S51;

  • The magnitude of the problem of peripheral arterial disease

    Amjad AlMahameed, MD, John R. Bartholomew, MD and Mary McGrae Mcdermott, MD
    • Cleveland Clinic Journal of Medicine October 2006, 73 (10 suppl 4) S2-S7;

  • Contemporary management of peripheral arterial disease

    Amjad AlMahameed, MD, John R. Bartholomew, MD, Teresa L. Carman, MD and Bernardo B. Fernandez Jr., MD
    • Cleveland Clinic Journal of Medicine October 2006, 73 (10 suppl 4) S38-S44;

  • New treatments for peripheral artery disease

    John Bartholomew, MD and G. Jay Bishop, MD
    • Cleveland Clinic Journal of Medicine May 2020, 87 (5 suppl 1) 21-25;
    • DOI: https://doi.org/10.3949/ccjm.87.s1.03

  • Putting the latest data into practice

    Holly L. Thacker, MD, FACP, Margaret McKenzie, MD, FACOG, Andrea L. Sikon, MD, FACP, Margery Gass, MD, Howard N. Hodis, MD and Marjorie R. Jenkins, MD
    • Cleveland Clinic Journal of Medicine May 2008, 75 (5 suppl 4) S25-S33;

    • This supplement is based on the proceedings of a roundtable convened at the Cleveland Clinic on January 17, 2008, by the Cleveland Clinic Journal of Medicine.

Previous
Next